(^202) Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff.
(2008).
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008).
(^203) Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008).
(^204) Fiore, M. C., Jorenby, D. E., Baker, T. B., & Kenford, S. L. (1992).
Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008).
(^205) Alpert, H. R., Connolly, G. N., & Biener, L. (2012).
(^206) National Institute on Drug Abuse. (2009c).
(^207) Centers for Disease Control and Prevention. (2002b).
(^208) Centers for Disease Control and Prevention. (2002b).
Tinsley, J. A. (2011).
(^209) McLellan, A. T. (2008).
Sadovsky, R. (2000).
(^210) Centers for Disease Control and Prevention. (2002b).
McLellan, A. T. (2008).
(^211) National Library of Medicine. (2009).
(^212) Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005).
Gowing, L., Farrell, M., Bornemann, R., Sullivan, L., & Ali, R. (2008).
Hubbard, R. L., Craddock, S. G., Flynn, P. M., Anderson, J., & Etheridge, R. M. (1997).
Kleber, H. D. (2008).
Marsch, L. A. (1998).
Meandzija, B., O'Connor, P. G., Fitzgerald, B., Rounsaville, B. J., & Kosten, T. R. (1994).
Executive Office of the President, Office of National Drug Control Policy. (2000).
(^213) Drug Enforcement Administration. (2011).
(^214) Fingerhut, L. A. (2008).
(^215) National Highway Traffic Safety Administration. (2012).
(^216) U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration,
Center for Substance Abuse Treatment. (2009).
(^217) Executive Office of the President, Office of National Drug Control Policy. (2000).
(^218) Centers for Disease Control and Prevention. (2002b).
U.S. Drug Enforcement Administration, Office of Diversion Control. (2011).
(^219) National Drug Intelligence Center. (2004).
(^220) Center for Substance Abuse Treatment. (2011).
(^221) Center for Substance Abuse Treatment. (2011).
(^222) U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2002).
(^223) Comer, S. D., Sullivan, M. A., Vosburg, S. K., Manubay, J., Amass, L., Cooper, Z. D., et al. (2010).
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2002).
(^224) Center for Substance Abuse Treatment. (2012).
(^225) Center for Substance Abuse Treatment, Division of Pharmacologic Therapies. (2012).
Jones, H. E. (2004).
(^226) Center for Substance Abuse Treatment, Division of Pharmacologic Therapies. (2012).
(^227) New York Department of Health. (2011).
National Institute on Drug Abuse. (2012d).
Sobel, B.-F. X., Sigmon, S. C., Walsh, S. L., Johnson, R. E., Liebson, I. A., Nuwayser, E. S., et al. (2004).
(^228) Amass, L., Kamien, J. B., & Mikulich, S. K. (2000).
Johnson, R. E., Chutuape, M. A., Strain, E. C., Walsh, S. L., Stitzer, M. L., & Bigelow, G. E. (2000).
Schottenfeld, R. S., Pakes, J., O'Connor, P., Chawarski, M., Oliveto, A., & Kosten, T. R. (2000).
(^229) Lanier, R. K., Umbricht, A., Harrison, J. A., Nuwayser, E. S., & Bigelow, G. E. (2007).
Sobel, B.-F. X., Sigmon, S. C., Walsh, S. L., Johnson, R. E., Liebson, I. A., Nuwayser, E. S., et al. (2004).
(^230) Center for Substance Abuse Treatment. (2012).
(^231) Center for Substance Abuse Treatment. (2004).
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., et al. (2011).
(^232) Amato, L., Davoli, M., Perucci, C. A., Ferri, M., Faggiano, F., & Mattick, R. P. (2005).
(^233) Boothby, L. A., & Doering, P. L. (2007).
Ling, W., Charuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Jr., Kintaudi, P., et al. (1998).
lu
(lu)
#1